- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Case of primary orbital melanoma causing Recurrent Orbital Hemorrhage in elderly patient
A patient in their 70s presented to the emergency department (ED) with a unilateral painless right proptosis, first noticed 3 days prior. There was no contributory medical history, recent trauma, or surgery. Visual acuity (VA) was 20/32 OD and 20/20 OS. Anterior segment and fundus examination results were normal. Magnetic resonance imaging (MRI) of the orbits revealed a right retro-orbital hemorrhage. No etiology could be identified on the image. Systemic corticosteroid therapy (methylprednisolone, 1 mg/kg per day) was prescribed for 48 hours. The proptosis decreased, and the patient was discharged.
After 6 months, complete ophthalmologic examination was performed again; VA was 20/20 OU, and there was no remaining proptosis. Two weeks later, the patient presented to the ED for another episode of acute, painless, right proptosis, and the VA had decreased to 20/40OD. MRI showed a right retrobulbar hemorrhage. Systemic corticosteroid therapy was again prescribed for 48 hours with rapid resolution of the visual impairment but incomplete resolution of the proptosis.
One month later, the patient presented to ophthalmology department. The VA was 20/20 OU, with a persistent, mild, nonreducible, nonpulsatile proptosis unrelated to Valsalva maneuver but associated with extraocular movement limitation in upgaze. A repeated MRI was performed.
Patient was diagnosed having Recurrent retrobulbar hemorrhage owing to an orbital tumor: a primary orbital melanoma. Additional imaging, including a computed tomography and positron emission tomography scan was done.
The differential diagnosis of a retrobulbar hemorrhage includes orbital trauma; recent orbital, eyelid, lacrimal, or sinus surgery; orbital vascular anomalies; Valsalva-related hemorrhage in a patient with sinonasal carcinoma; and primary orbital tumor ormetastasis. In this patient, there was no history of recent trauma or orbital or periorbital surgery. This presentation—recurrent retrobulbar hemorrhage associated with orbital mass effect over several weeks and restriction in upgaze—suggested an orbital tumor history but was not specific enough to eliminate an orbital vascular anomaly.
MRI was needed to differentiate between a vascular or tissular lesion. The isointensity of the lesion in T1- and T2-weighted images was in favor of a tissular lesion; avascular or cystic lesion would be hyperintense on T2-weighted images. These findings supported a retrobulbar tumor surrounding the optic nerve.
Additional imaging was needed for disease staging and treatment planning. Computed tomography (CT) imaging of the orbital region can show bony involvement (osteolysis), which, if present, can help in surgical planning. CT imaging of the cranial, neck, thoracic, and abdominal regions can show primary disease or metastasis. Positron emission tomography (PET) imaging can assess the metabolic uptake of the orbital lesion and is more sensitive than CT imaging in cancer staging. Angiography is not helpful as an initial imaging modality; orbital vascular anomalies are unlikely owing to the tissue like aspect of the lesion.
In this case, CT imaging showed no osteolysis, and PET imaging revealed hypermetabolism of the orbital tumor without the presence of other hypermetabolic lesions. An inferior transconjunctival orbital biopsy was performed. Histologic examination confirmed a primary melanoma. This biopsy should be done after cancer staging imaging so as not to miss another, more accessible site of biopsy.
Nonmetastatic malignant melanoma treatment involves complete surgical removal with safety margins. Evisceration or enucleation were not an option in this patient as the tumor was primarily intraorbital and not intraocular. Ultimately, eyelid-sparing exenteration was performed, followed by radiotherapy. The primary meningeal melanoma originated in the optic nerve, developed in the posterior orbit, and infiltrated the oculomotor muscles, orbital fat, and sclera without intraocular extension. Genetic testing was positive for the GNAQ variant and negative for the BRAF variant. Unfortunately, the patient developed a hepatic metastasis diagnosed on postradiotherapy imaging. The patient died a few months later.
Source: Alexis Mathieu; Romain Nicot; Matthias Schlund; JAMA Ophthalmology Clinical Challenge
doi:10.1001/jamaophthalmol.2022.2875
Dr Ishan Kataria has done his MBBS from Medical College Bijapur and MS in Ophthalmology from Dr Vasant Rao Pawar Medical College, Nasik. Post completing MD, he pursuid Anterior Segment Fellowship from Sankara Eye Hospital and worked as a competent phaco and anterior segment consultant surgeon in a trust hospital in Bathinda for 2 years.He is currently pursuing Fellowship in Vitreo-Retina at Dr Sohan Singh Eye hospital Amritsar and is actively involved in various research activities under the guidance of the faculty.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751